Table 6.1.1: Stock and Flow, *based on year of death Year

Slides:

Advertisements

Similar presentations

Cemetery Demography Lab October Table 3: Data Calculations for Survivorship Curve Age Class Years # Deaths in Class (d) # Surviving from Birth (I)

Advertisements

CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato’ Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

CHAPTER 2 CORNEAL TRANSPLANTATION

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

CHAPTER 4 LIVER TRANSPLANTATION Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way.

Table 2.1.1: Number of Cornea Transplantation and Transplant Rate per million population (pmp), Year No.

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

Table 2.1.1: New Transplant Rate per million population (pmp), Year New transplants

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths

CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.

CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.

CHAPTER 1 BLOOD AND MARROW TRANSPLANTATION Editors: Dr Alan Teh Kee Hean Prof Dr Chan Lee Lee Expert Panel: Dr Alan Teh Kee Hean (co-chairperson) Prof.

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

 Kidney  Pancreas  Liver  Heart 1954 by Murray/Harrison 1966 by Lillehei 1967 by Starzl 1968 by Barnard.

Table 6.1.1: Stock and Flow, Year New transplant Deaths* Lost.

CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,

Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths

CHAPTER 6 HOMOGRAFT - HEART VALVE TRANSPLANTATION Editor: Mr Mohamed Ezani Md. Taib Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais.

CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths

Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.

Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths

CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths

Table 2.1.1: Number of Corneal Transplantation and Transplant Rate per million population (pmp), Year

THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY

Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014

First-year death rates by modality figure 8

Table 3.1.1a: Stock and Flow of Heart Transplantation,

BCLC Outperforms HKLC Staging of Hepatocellular Carcinoma in Multiethnic Asians – Real-World Perspective ESPS Manuscript NO:

Number of procurement by year

Mortality rates in incident ESRD patients figure 9

Number of transplants, by donor type figure 8.1

UK Renal Registry 16th Annual Report

December 31st point prevalent counts by modality figure 3.1

HEART-LUNG TRANSPLANTATION

CHAPTER 5 Paediatric Renal Replacement Therapy

Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients

CHAPTER 11: Haemodialysis Practices

ANZDATA Registry Annual Report 2013

CHAPTER 1 All Renal Replacement Therapy In Malaysia

HEART-LUNG TRANSPLANTATION

CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder

THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation,

Christopher Lim Thiam Seong

HEART-LUNG TRANSPLANTATION

Prosthesis size and long-term survival after aortic valve replacement

HEART-LUNG TRANSPLANTATION

National Cancer Statistics in Korea, 2015

UK Cystic Fibrosis Registry Annual Data Report 2017

CAP RESULTS Cumulative Results January 31, 2002.

Chapter 4 SURVIVAL AND LIFE TABLES

HEART-LUNG TRANSPLANTATION

Ruth H. Keogh, Sanja Stanojevic Journal of Cystic Fibrosis

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

Table I Male Disc Participants: Mean (S.D.)

Number of Donors in Australia

Stock and Flow of Haemodialysis Patients Australia

Demographic Characteristics of Cohort

Table 6.1.1: Stock and Flow, Year

Figure Prevalence of coronary artery disease by year or

Stock and Flow of Haemodialysis Patients Australia

HEART-LUNG TRANSPLANTATION

Presentation transcript:

Table 6.1.1: Stock and Flow, 1996-2006 *based on year of death Year 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 New transplant 4 32 22 17 13 20 21 9 3 Deaths* 1 2 Lost to follow up Alive with functioning graft at 31st December 35 53 67 80 97 116 135 141 144 148 *based on year of death

Figure 6.1.1: Stock and Flow, 1996-2006 Number of patients (n) Year 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 New patients Alive at 31st Dec 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Table 6.2.1: Distribution of Patients by Gender, 1996-2006 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL Gender No. Male 2 19 9 10 6 14 3 4 85 Female 13 8 7 82 32 22 17 20 21 167

Figure 6.2.1: Distribution of Patients by Gender, 1996-2006 Number of patients (n) Year 2 4 6 8 10 12 14 16 18 20 Male Female 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Table 6.2.2: Distribution of Patients by Ethnic Group, 1996-2006 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL Ethnic group No. Malay 1 19 15 9 10 16 12 6 3 2 102 Chinese 11 4 44 Indian 13 Others 8 32 22 17 20 21 167

Figure 6.2.2: Distribution of Patients by Ethnic Group, 1996-2006 Number of patients (n) Year 2 4 6 8 10 12 14 16 18 20 Malay Chinese Indian Others 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Table 6.2.3: Distribution of Patients by Age, 1996-2006 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL Age group No. 0-9 2 15 12 10 14 11 4 1 95 10-19 13 5 8 3 52 20-39 40-59 >=60 32 22 17 20 21 9 167 Mean 7 SD 6 Median Min 3 months 5 months Max 30 70 67 53 28 42 * Age=date of implantation – date birth

Figure 6.2.3: Distribution of Patients by Age, 1996-2006 Number of patients (n) Year 2 4 6 8 10 12 14 16 0-9 years 10-19 years 20-39 years 40-59 years ≥60 years 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Table 6.3.2: Type of Transplant, 1996-2006 Table 6.3.1: Number of Valves Harvested by Type of Homograft, 1996-2006 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL Type of homograft No. Aortic 8 17 10 11 14 7 4 15 112 Pulmonary 1 12 9 5 111 31 21 18 23 26 24 30 223 Table 6.3.2: Type of Transplant, 1996-2006 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 TOTAL Type of transplant No. Aortic 4 19 11 7 9 10 1 83 Pulmonary 13 6 12 5 2 3 84 32 22 17 20 21 167

Figure 6.3.2: Type of Transplant, 1996-2006 Number of patients (n) Year 2 4 6 8 10 12 14 16 18 20 Aortic Pulmonary 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006

Table 6.4.1: Patient Survival by Gender, 1996-2006 Male Female Interval (years) % Survival SE 1 91 3 93 89 4 5 SE=standard error

Figure 6.4.1: Patient Survival by Gender, 1996-2006 0.00 0.25 0.50 0.75 1.00 Cumulative survival 1 2 3 4 5 Duration in years Female Male

Table 6.4.2: Patient Survival by Age Group, 1996-2006 0-9 years 10-19 years ≥20 years Interval (months) % Survival SE 1 89 3 96 95 5 88 92 4 SE=standard error

Figure 6.4.2: Patient Survival by Age Group, 1996-2006 0.00 0.25 0.50 0.75 1.00 Cumulative survival 1 2 3 4 5 Duration in years 0-9 years 10-19 years >=20 years

Table 6.4.3: Patient Survival by Type of Homograft, 1996-2006 Aortic Pulmonary Interval (years) % Survival SE 1 93 3 91 89 4 5

Figure 6.4.3: Patient Survival by Type of Homograft, 1996-2006 0.00 0.25 0.50 0.75 1.00 Cumulative survival 1 2 3 4 5 Duration in years Aortic Pulmonary